A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jae K Oh, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institut Universitaire de Cardiologie Et de Pneumologie de Québec - Université Laval
Québec, Canada
- Mayo Clinic, Az
Phoenix, Arizona, United States
- University of Southern California
Los Angeles, California, United States
- University of Colorado
Aurora, Colorado, United States
- Mayo Clinic, Fl
Jacksonville, Florida, United States
- Baycare Health Systems
Safety Harbor, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Beaumont Hospital, Royal Oak
Royal Oak, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Hackensack Meridian Health
Hackensack, New Jersey, United States
- Rutgers- Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Ichan School of Medicine
New York, New York, United States
- Stony Brook
Stony Brook, New York, United States
- Christ Hospital
Cincinnati, Ohio, United States
- Ohiohealth Research Institute
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pittsburgh Medical Center
Mechanicsburg, Pennsylvania, United States
- Einstein Medical Center Philadelphia
Philadelphia, Pennsylvania, United States
- Texas Heart Institute
Houston, Texas, United States
- the University of Vermont Medical Center
Burlington, Vermont, United States
- Inova Health Care Services
Falls Church, Virginia, United States
- Aurora Research Institute
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jun 2022
- Primary completion
- 15 May 2026
- Completion
- 30 Dec 2026
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 580
- Registry id
- NCT05143177
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.